TA Associates Makes Strategic Growth Investment in Diatech Pharmacogenetics
April 26, 2023
TA Associates has signed a definitive agreement to make a strategic growth investment in Diatech Pharmacogenetics, a Jesi, Italy–based developer and manufacturer of molecular diagnostics for precision oncology. Minority investor Alto Partners will fully exit while Diatech's founder and management retain majority ownership; the capital will support product development and international expansion.
- Buyers
- TA Associates
- Targets
- Diatech Pharmacogenetics
- Sellers
- Alto Partners
- Industry
- Biotechnology
- Location
- Marche, Italy
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
TA Associates Completes Strategic Growth Investment in Vee Healthtek
November 18, 2024
Healthcare Services
TA Associates completed a strategic growth investment in Vee Healthtek to support the company's expansion of technology-enabled services for healthcare organizations. The partnership will help Vee Healthtek enhance its technology capabilities, expand offerings (organically and via M&A) across revenue cycle management, health information management, analytics, risk adjustment and claims management; financial terms were not disclosed.
-
TA Associates Makes Strategic Growth Investment in Synokem Pharmaceuticals
January 18, 2023
Pharmaceuticals
TA Associates completed a strategic growth investment in Synokem Pharmaceuticals Ltd., with Synokem's founders remaining shareholders. The investment will support Synokem—an India-based CDMO with operations in New Delhi and manufacturing/R&D in Haridwar—to drive organic growth and pursue strategic acquisitions and capability expansion for domestic and international markets.
-
TA Associates Makes Strategic Growth Investment in HealthMark Group
July 30, 2025
Healthcare Services
TA Associates has made a strategic growth investment in HealthMark Group, a Dallas-based provider of clinical information exchange solutions. Management and existing investor Ridgemont Equity Partners rolled meaningful stakes as TA becomes the new lead investor to accelerate HealthMark's growth, expand capabilities, and broaden market reach.
-
TA Associates Makes Strategic Growth Investment in Zifo RnD Solutions
May 9, 2022
Data & Analytics
TA Associates completed a strategic growth investment in Zifo RnD Solutions, a Chennai-headquartered provider of scientific informatics and R&D digital transformation services for the life sciences. The partnership will support Zifo’s global expansion and capability development as it scales its informatics, data science and managed services for pharma, biotech and medical device customers.
-
TA Associates Invests in PDQ.com
August 24, 2021
Software
TA Associates has made a growth investment in PDQ.com, a Salt Lake City–headquartered provider of IT asset management and endpoint management software. The investment will support PDQ's product portfolio expansion and accelerate growth alongside the company's founders and management team.
-
TA Associates Makes Growth Investment in Rocscience
January 8, 2024
Software
TA Associates completed a strategic growth investment in Rocscience, a Toronto-based developer of 2D and 3D geotechnical engineering software. The investment will support Rocscience's product and go-to-market expansion, accelerate R&D and inorganic growth initiatives; TA partners will join Rocscience's board while founder Dr. John Curran remains on the board. Financial terms were not disclosed.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.